Literature DB >> 23814122

Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.

Florent Valour1, Stéphane Durupt, Safia Khenifer, Isabelle Durieu.   

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterised by chronic cholestasis usually associated with antimitochondrial antibodies. Moreover, several types of antinuclear antibodies have been associated with primary biliary cirrhosis. We describe an 83-year-old man, in whom the exploration of a chronic cholestasis led to the diagnosis of primary biliary cirrhosis despite negative antimitochondrial antibodies, regarding the presence of anti-gp210 antibodies. Found in 25% of patients, these antinuclear antibodies must be sought before a strong suspicion of primary biliary cirrhosis with antimitochondrial antibodies negative, as they are highly specific of the disease. They are generally associated with a more aggressive form of PBC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23814122      PMCID: PMC3702913          DOI: 10.1136/bcr-2013-009803

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

Review 1.  The pruritus of cholestasis.

Authors:  Nora V Bergasa
Journal:  J Hepatol       Date:  2005-10-06       Impact factor: 25.083

2.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

Authors: 
Journal:  J Hepatol       Date:  2009-06-06       Impact factor: 25.083

3.  Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis.

Authors:  A Ruffatti; P Arslan; A Floreani; G De Silvestro; A Calligaro; R Naccarato; S Todesco
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

4.  Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.

Authors:  Minoru Nakamura; Yuki Shimizu-Yoshida; Yasushi Takii; Atsumasa Komori; Terufumi Yokoyama; Toshihito Ueki; Manabu Daikoku; Koji Yano; Takehiro Matsumoto; Kiyoshi Migita; Hiroshi Yatsuhashi; Masahiro Ito; Naohiko Masaki; Hiroshi Adachi; Yukio Watanabe; Yoko Nakamura; Takeo Saoshiro; Takeshi Sodeyama; Michiaki Koga; Shinji Shimoda; Hiromi Ishibashi
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

5.  The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.

Authors:  J C Courvalin; K Lassoued; E Bartnik; G Blobel; R W Wozniak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis.

Authors:  K Lassoued; M N Guilly; C Andre; M Paintrand; D Dhumeaux; F Danon; J C Brouet; J C Courvalin
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

7.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

Authors:  P M Huet; J Deslauriers; A Tran; C Faucher; J Charbonneau
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

8.  Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.

Authors:  R E Nickowitz; R W Wozniak; F Schaffner; H J Worman
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

9.  Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study.

Authors:  Kiyomitsu Miyachi; Raleigh W Hankins; Hiroshi Matsushima; Futoshi Kikuchi; Tetushi Inomata; Tuneyoshi Horigome; Minoru Shibata; Yasushi Onozuka; Yukihisa Ueno; Etsuko Hashimoto; Naoaki Hayashi; Akitaka Shibuya; Shuichi Amaki; Hiroshi Miyakawa
Journal:  J Autoimmun       Date:  2003-05       Impact factor: 7.094

10.  Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.

Authors:  Alicja Bauer; Andrzej Habior
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

View more
  1 in total

Review 1.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.